The subject of this publication is the conclusion of agreements on contrast agents with various active substances or drug combinations within the framework of a so-called “open house model” to ensure the cost-effectiveness of obtaining contrast agents in the context of Hessian consultation hours (SSB).

The accession or the conclusion of the contract can take place at any time and under the same conditions. Individual contract negotiations are not carried out.

The earliest start date of the contract is 01.12.2023. Based on this, the contract period is a maximum of 24 months. The contract ends on 30.11.2025 regardless of the beginning of the contract. If, during the term of the contract, AOK Hessen conducts a tender for exclusive contracts in the form of an open procedure for the active substances or combinations of active ingredients, the contracts concluded within the framework of this publication will be terminated in accordance with the contractual provisions.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.

Providing uniform contractual conditions and a uniform access procedure, all suitable and interested contractors (pharmaceutical companies including importers, manufacturers, wholesalers, pharmacies) will be able to conclude or join a discount agreement for the aforementioned active ingredients and drug combinations offered. Interested parties can request the participation documents and the contract at the contact address mentioned under I.1. after concluding a non-disclosure agreement with AOK Hessen. The prerequisite for concluding a contract is that the interested contractor submits the requested non-disclosure agreement and participation documents completely completed and signed. A contract is concluded with every interested party who meets the requirements for participation. No exclusivity is given.The present publication does not constitute the award of a public contract within the meaning of Directive 2014/24/EU or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure name “open procedure” or the information under item IV.2.2 “Conditions for the opening of offers”, are solely due to the use of this announcement form and the publication platform. The data provided under item IV2.7 should therefore be regarded as fictitious information. This does not implore any further significance, in particular submission to public procurement regulations, unless they are mandatory for legal reasons.